Holen Sie sich die Stockscreener-App
8.18
1.49%
0.12
Handel nachbörslich:
8.18
Schlusskurs vom Vortag:
$8.06
Offen:
$8.18
24-Stunden-Volumen:
459.04K
Relative Volume:
0.39
Marktkapitalisierung:
$440.33M
Einnahmen:
$217.25M
Nettoeinkommen (Verlust:
$-50.92M
KGV:
-8.18
EPS:
-1
Netto-Cashflow:
$-100.85M
1W Leistung:
-2.97%
1M Leistung:
-4.10%
6M Leistung:
-36.24%
1J Leistung:
-61.92%
1-Tages-Spanne:
$8.05
$8.35
1-Wochen-Bereich:
$8.04
$8.49
52-Wochen-Spanne:
$4.32
$22.29
Prothena Corporation Plc Stock (PRTA) Company Profile
Firmenname
Prothena Corporation Plc
Sektor
Branche
Telefon
011-353-1-236-2500
Adresse
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Vergleichen Sie PRTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
8.18 | 433.87M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-27 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-01-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-04-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-06-18 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Bestätigt | Oppenheimer | Outperform |
| 2021-05-26 | Eingeleitet | Citigroup | Buy |
| 2021-02-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Herabstufung | Jefferies | Buy → Hold |
| 2018-04-05 | Bestätigt | Barclays | Overweight |
| 2017-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2017-09-29 | Bestätigt | BTIG Research | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2017-04-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-12-21 | Eingeleitet | SunTrust | Buy |
| 2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
| 2016-08-04 | Bestätigt | Barclays | Overweight |
| 2016-05-13 | Eingeleitet | Barclays | Overweight |
| 2016-02-19 | Bestätigt | Wedbush | Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
Is Prothena Corporation plc attractive for institutional investorsWeekly Profit Recap & Daily Stock Trend Watchlist - خودرو بانک
What is Zacks Research's Forecast for Prothena Q1 Earnings? - MarketBeat
Evaluating Prothena Corporation plc with trendline analysisInflation Watch & Long Hold Capital Preservation Plans - newser.com
Using Bollinger Bands to evaluate Prothena Corporation plc2025 Volatility Report & AI Driven Stock Movement Reports - newser.com
Understanding Prothena Corporation plc’s price movementWeekly Loss Report & Real-Time Volume Analysis - newser.com
Aug Chart Watch: Will Prothena Corporation plc stock go up in YEARJuly 2025 WrapUp & Reliable Intraday Trade Plans - خودرو بانک
Goldman Sachs Group Inc. Trims Stock Position in Prothena Corporation plc $PRTA - MarketBeat
Published on: 2025-09-17 17:25:31 - newser.com
Weekly Earnings: Whats the MACD signal for Prothena Corporation plcBond Market & Real-Time Volume Analysis Alerts - خودرو بانک
Siren L.L.C. Grows Stake in Prothena Corporation plc $PRTA - MarketBeat
Is Prothena Corporation plc building a consolidation baseEarnings Beat & Free Low Drawdown Momentum Trade Ideas - newser.com
Custom strategy builders for tracking Prothena Corporation plcJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
Aug Closing: Does BCPC offer margin of safetyWeekly Loss Report & Technical Confirmation Alerts - خودرو بانک
What machine learning models say about Prothena Corporation plcJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-09-15 23:10:47 - newser.com
Weekly Recap: Can Prothena Corporation plc generate free cash flowJuly 2025 Review & Community Trade Idea Sharing Platform - خودرو بانک
Technical Analysis: Should I buy Prothena Corporation plc stock now2025 Retail Activity & Stock Portfolio Risk Management - خودرو بانک
Aug Movers: Will Prothena Corporation plc benefit from rising consumer demandWeekly Gains Report & Daily Risk Controlled Trade Plans - خودرو بانک
Is Prothena Corporation plc stock poised for growthMarket Performance Report & Fast Moving Stock Watchlists - newser.com
Key metrics from Prothena Corporation plc’s quarterly dataGold Moves & Real-Time Chart Breakout Alerts - newser.com
Using data filters to optimize entry into Prothena Corporation plcJuly 2025 Patterns & Fast Entry High Yield Tips - newser.com
Technical signs of recovery in Prothena Corporation plcRecession Risk & Low Drawdown Investment Ideas - newser.com
Prothena Corporation plc (NASDAQ:PRTA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Applying Wyckoff theory to Prothena Corporation plc stockFed Meeting & Advanced Technical Analysis Signals - Newser
What moving averages say about Prothena Corporation plcJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser
Can volume confirm reversal in Prothena Corporation plcEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
Using data tools to time your Prothena Corporation plc exitMarket Rally & Growth Oriented Trade Recommendations - Newser
Short interest data insights for Prothena Corporation plcWatch List & Growth Focused Entry Point Reports - Newser
Visual trend scoring systems applied to Prothena Corporation plcWeekly Market Outlook & Fast Exit and Entry Trade Guides - Newser
Institutional scanner results for Prothena Corporation plcJuly 2025 Intraday Action & Community Trade Idea Sharing - Newser
Has Prothena Corporation plc formed a bullish divergenceMarket Performance Report & Free Expert Approved Momentum Trade Ideas - Newser
Using fundamentals and technicals on Prothena Corporation plcWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Can swing trading help recover from Prothena Corporation plc lossesJuly 2025 Trade Ideas & Daily Market Momentum Tracking - Newser
Prothena Down 40% Year to Date: What Lies Ahead for the Stock? - Yahoo Finance
Analysts Set Prothena Corporation plc (NASDAQ:PRTA) Target Price at $19.75 - Defense World
Relative strength of Prothena Corporation plc in sector analysisQuarterly Portfolio Report & Real-Time Market Sentiment Reports - Newser
Automated trading signals detected on Prothena Corporation plcJuly 2025 Sentiment & Accurate Buy Signal Notifications - Newser
Will Prothena Corporation plc price bounce be sustainableMarket Movement Recap & Consistent Profit Trading Strategies - Newser
Published on: 2025-09-10 05:55:27 - Newser
Finanzdaten der Prothena Corporation Plc-Aktie (PRTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):